Cosmo Pharmaceuticals N.V. | Balance Sheet
Fiscal year is January-December. All values CHF Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
206,077.90
71,497.50
126,505.40
178,471.10
202,093.50
393,785.50
Total Accounts Receivable
17,213.10
8,901.10
19,586.00
18,366.50
19,732.70
17,843.60
Inventories
3,503.60
4,272.00
2,443.40
2,469.90
3,792.60
4,436.70
Other Current Assets
4,001.20
347.50
1,448.40
1,234.90
5,264.60
5,589.50
Total Current Assets
230,795.80
85,018.10
149,983.20
200,542.40
230,883.50
421,655.30
Net Property, Plant & Equipment
26,597.80
25,784.70
22,976.50
22,160.30
35,283.30
32,247.90
Total Investments and Advances
19,010.90
145,277.10
296,009.40
228,865.60
268,618.20
194,119.40
Long-Term Note Receivable
-
-
-
-
2,191.70
2,207.60
Intangible Assets
20,165.30
12,521.40
5,007.40
21,070.10
33,506.90
41,654.20
Total Assets
297,796.50
271,279.10
476,213.20
475,402.00
582,719.00
705,096.40
ST Debt & Current Portion LT Debt
2,433.80
2,404.70
1,690.90
910.10
759.40
Accounts Payable
5,094.30
6,572.10
4,655.10
6,510.20
13,255.80
Income Tax Payable
1,231.60
40,089.30
257.70
2,494.50
1,393.70
Other Current Liabilities
3,126.20
23,864.60
20,626.60
10,149.70
7,330.00
Total Current Liabilities
11,885.90
72,930.70
27,230.30
20,064.50
22,738.90
Long-Term Debt
11,963.10
10,737.10
7,152.80
4,781.10
4,478.30
Provision for Risks & Charges
504.90
539.90
431.70
438.40
372.10
Deferred Taxes
2,420.30
1,286.50
241.40
1,878.10
7,227.00
Total Liabilities
28,001.00
88,171.90
37,293.00
29,925.80
32,597.70
Common Equity (Total)
269,777.10
183,091.50
438,907.20
445,463.30
550,121.30
Total Shareholders' Equity
269,777.10
183,091.50
438,907.20
445,463.30
550,121.30
Total Equity
269,795.50
183,107.10
438,920.20
445,476.20
550,121.30
Liabilities & Shareholders' Equity
297,796.50
271,279.10
476,213.20
475,402.00
582,719.00
Accumulated Minority Interest
18.40
15.60
13.00
12.90
-
About Cosmo Pharmaceuticals
View Profile
